These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9914442)
21. Effects of cocaine on extrapyramidal and limbic dynorphin systems. Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755 [TBL] [Abstract][Full Text] [Related]
22. Application of electrophysiological method to study interactions between ibogaine and cocaine. Binienda Z; Beaudoin MA; Thorn BT; Sadovova N; Skinner RD; Slikker W; Ali SF Ann N Y Acad Sci; 2000 Sep; 914():387-93. PubMed ID: 11085337 [TBL] [Abstract][Full Text] [Related]
23. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Adams DH; Hanson GR; Keefe KA Neuroscience; 2001; 102(4):843-51. PubMed ID: 11182247 [TBL] [Abstract][Full Text] [Related]
25. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems. Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999 [TBL] [Abstract][Full Text] [Related]
26. Characterization of dopaminergic influence on striatal-nigral neurotensin systems. Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151 [TBL] [Abstract][Full Text] [Related]
27. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Glick SD; Kuehne ME; Raucci J; Wilson TE; Larson D; Keller RW; Carlson JN Brain Res; 1994 Sep; 657(1-2):14-22. PubMed ID: 7820611 [TBL] [Abstract][Full Text] [Related]
28. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice. Betancur C; Lépée-Lorgeoux I; Cazillis M; Accili D; Fuchs S; Rostène W Neuropsychopharmacology; 2001 Feb; 24(2):170-82. PubMed ID: 11120399 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of antiaddictive actions of ibogaine. Glick SD; Maisonneuve IS Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680 [TBL] [Abstract][Full Text] [Related]
30. Development of novel medications for drug addiction. The legacy of an African shrub. Glick SD; Maisonneuve IM Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925 [TBL] [Abstract][Full Text] [Related]
31. The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. Hanson GR; Singh N; Merchant K; Johnson M; Gibb JW Drug Alcohol Depend; 1995 Feb; 37(2):107-10. PubMed ID: 7758400 [TBL] [Abstract][Full Text] [Related]
32. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine. Szumlinski KK; Maisonneuve IM; Glick SD Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838 [TBL] [Abstract][Full Text] [Related]
33. Effect of methamphetamine on neurotensin concentrations in rat brain regions. Letter AA; Merchant K; Gibb JW; Hanson GR J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804 [TBL] [Abstract][Full Text] [Related]
34. [Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex]. Masuda T; Fujimoto H; Kawai H; Saito S Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):362-74. PubMed ID: 2842204 [TBL] [Abstract][Full Text] [Related]
36. Responses of limbic and extrapyramidal substance P systems to nicotine treatment. Alburges ME; Frankel PS; Hoonakker AJ; Hanson GR Psychopharmacology (Berl); 2009 Jan; 201(4):517-27. PubMed ID: 18773198 [TBL] [Abstract][Full Text] [Related]
37. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Hanson GR; Keefe KA Brain Res Mol Brain Res; 1999 Mar; 66(1-2):111-21. PubMed ID: 10095083 [TBL] [Abstract][Full Text] [Related]
38. Chronic continuous or intermittent infusion of cocaine differentially alter the concentration of neurotensin-like immunoreactivity in specific rat brain regions. Cain ST; Griff D; Joyner CM; Ellinwood EH; Nemeroff CB Neuropsychopharmacology; 1993 May; 8(3):259-65. PubMed ID: 8507352 [TBL] [Abstract][Full Text] [Related]
39. Iboga interactions with psychomotor stimulants: panacea in the paradox? Szumlinski KK; Maisonneuve IM; Glick SD Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624 [TBL] [Abstract][Full Text] [Related]
40. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Barrett AC; Miller JR; Dohrmann JM; Caine SB Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]